174 related articles for article (PubMed ID: 27604082)
1. Allopurinol and the risk of stroke in older adults receiving medicare.
Singh JA; Yu S
BMC Neurol; 2016 Sep; 16(1):164. PubMed ID: 27604082
[TBL] [Abstract][Full Text] [Related]
2. Allopurinol reduces the risk of myocardial infarction (MI) in the elderly: a study of Medicare claims.
Singh JA; Yu S
Arthritis Res Ther; 2016 Sep; 18(1):209. PubMed ID: 27655429
[TBL] [Abstract][Full Text] [Related]
3. Allopurinol and the risk of incident peripheral arterial disease in the elderly: a US Medicare claims data study.
Singh JA; Cleveland J
Rheumatology (Oxford); 2018 Mar; 57(3):451-461. PubMed ID: 29106674
[TBL] [Abstract][Full Text] [Related]
4. Allopurinol and the risk of atrial fibrillation in the elderly: a study using Medicare data.
Singh JA; Yu S
Ann Rheum Dis; 2017 Jan; 76(1):72-78. PubMed ID: 27165177
[TBL] [Abstract][Full Text] [Related]
5. The association of gout with incident giant cell arteritis in older adults.
Singh JA; Cleveland JD
Joint Bone Spine; 2019 Mar; 86(2):219-224. PubMed ID: 29885976
[TBL] [Abstract][Full Text] [Related]
6. Allopurinol and the risk of ventricular arrhythmias in the elderly: a study using US Medicare data.
Singh JA; Cleveland J
BMC Med; 2017 Mar; 15(1):59. PubMed ID: 28327188
[TBL] [Abstract][Full Text] [Related]
7. Gout and dementia in the elderly: a cohort study of Medicare claims.
Singh JA; Cleveland JD
BMC Geriatr; 2018 Nov; 18(1):281. PubMed ID: 30428833
[TBL] [Abstract][Full Text] [Related]
8. Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes.
Singh JA; Ramachandaran R; Yu S; Curtis JR
BMC Cardiovasc Disord; 2017 Mar; 17(1):76. PubMed ID: 28288564
[TBL] [Abstract][Full Text] [Related]
9. Are allopurinol dose and duration of use nephroprotective in the elderly? A Medicare claims study of allopurinol use and incident renal failure.
Singh JA; Yu S
Ann Rheum Dis; 2017 Jan; 76(1):133-139. PubMed ID: 27296322
[TBL] [Abstract][Full Text] [Related]
10. Comparative effectiveness of allopurinol versus febuxostat for preventing incident renal disease in older adults: an analysis of Medicare claims data.
Singh JA; Cleveland JD
Ann Rheum Dis; 2017 Oct; 76(10):1669-1678. PubMed ID: 28584186
[TBL] [Abstract][Full Text] [Related]
11. The risk of Sjogren's syndrome in the older adults with gout: A medicare claims study.
Singh JA; Cleveland JD
Joint Bone Spine; 2019 Oct; 86(5):615-619. PubMed ID: 30738190
[TBL] [Abstract][Full Text] [Related]
12. Gout and chronic pain in older adults: a Medicare claims study.
Singh JA; Cleveland JD
Clin Rheumatol; 2019 Jul; 38(7):1953-1960. PubMed ID: 30927116
[TBL] [Abstract][Full Text] [Related]
13. Comparative effectiveness of allopurinol and febuxostat for the risk of atrial fibrillation in the elderly: a propensity-matched analysis of Medicare claims data.
Singh JA; Cleveland JD
Eur Heart J; 2019 Sep; 40(36):3046-3054. PubMed ID: 30919894
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol: Population-Based Cohort Study.
Zhang M; Solomon DH; Desai RJ; Kang EH; Liu J; Neogi T; Kim SC
Circulation; 2018 Sep; 138(11):1116-1126. PubMed ID: 29899013
[TBL] [Abstract][Full Text] [Related]
15. Gout is associated with a higher risk of chronic renal disease in older adults: a retrospective cohort study of U.S. Medicare population.
Singh JA; Cleveland JD
BMC Nephrol; 2019 Mar; 20(1):93. PubMed ID: 30876398
[TBL] [Abstract][Full Text] [Related]
16. Gout and the risk of Parkinson's disease in older adults: a study of U.S. Medicare data.
Singh JA; Cleveland JD
BMC Neurol; 2019 Jan; 19(1):4. PubMed ID: 30611222
[TBL] [Abstract][Full Text] [Related]
17. Comparative effectiveness of allopurinol versus febuxostat for preventing incident dementia in older adults: a propensity-matched analysis.
Singh JA; Cleveland JD
Arthritis Res Ther; 2018 Aug; 20(1):167. PubMed ID: 30075731
[TBL] [Abstract][Full Text] [Related]
18. Gout and the risk of incident depression in older adults.
Singh JA; Cleveland JD
Psychiatry Res; 2018 Dec; 270():842-844. PubMed ID: 30551333
[TBL] [Abstract][Full Text] [Related]
19. Allopurinol therapy in gout patients does not associate with beneficial cardiovascular outcomes: a population-based matched-cohort study.
Kok VC; Horng JT; Chang WS; Hong YF; Chang TH
PLoS One; 2014; 9(6):e99102. PubMed ID: 24897240
[TBL] [Abstract][Full Text] [Related]
20. The risk of polymyalgia rheumatica in older adults with gout: a Medicare claims study.
Singh JA; Cleveland JD
Rheumatol Adv Pract; 2018; 2(2):rky024. PubMed ID: 31431970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
